The prognosis for recovery from a spinal cord injury (SCI) is of great importance for those directly affected and those around them.
Genentech paves path to increased clinical trial diversity as a ‘business imperative’
Genentech is aiming to lead the charge for clinical trial diversity in the pharma industry and it’s using a mix of regulatory commitments, trial site